Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases-Reference-Cited by-同舟云学术

Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases

Published:2011-12 Issue:24 Volume:21 Page:7489-7495
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Miles Timothy J.,Axten Jeffrey M.,Barfoot Christopher,Brooks Gerald,Brown Pamela,Chen Dongzhao,Dabbs Steven,Davies David T.,Downie David L.,Eyrisch Susanne,Gallagher Timothy,Giordano Ilaria,Gwynn Michael N.,Hennessy Alan,Hoover Jennifer,Huang Jianzhong,Jones Graham,Markwell Roger,Miller William H.,Minthorn Elizabeth A.,Rittenhouse Stephen,Seefeld Mark,Pearson Neil

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference26 articles.

1. Drugs for bad bugs: confronting the challenges of antibacterial discovery

2. Antibiotics at the crossroads

3. New approaches to overcoming bacterial resistance

4. Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents

5. Safety Concerns with Fluoroquinolones

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel 4-substituted 7H-pyrrolo[2,3-d]pyrimidine derivatives as new FtsZ inhibitors: Bioactivity evaluation and computational simulation;Bioorganic Chemistry;2024-09

2. Why Matter Matters: Fast-Tracking Mycobacterium abscessus Drug Discovery;Molecules;2022-10-17

3. The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV;Journal of Medicinal Chemistry;2022-05-03

4. Structure–Activity Relationship of Anti-Mycobacterium abscessus Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase Inhibitors;ACS Medicinal Chemistry Letters;2022-02-28

5. Solid-phase synthesis and biological evaluation of piperazine-based novel bacterial topoisomerase inhibitors;Bioorganic & Medicinal Chemistry Letters;2022-02